BIRC5 and ovarian carcinoma: In three studies reporting survivin expression in ovarian carcinoma and normal ovarian tissue, we did not observe any heterogeneity between the two groups (I2 = 0.00%, H2 = 1.0, p = 0.82); therefore, we used the fixed-effects model for analysis (Figure 2).